Asia Pacific Pharmaceutical Sector Analysis

Report Overview

Table of Contents

720

Select License Type

£720.00	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£1,200.00	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.
£840.00	Hard Copy License Hard Copy License As described. Hard copy reports are dispatched in the post/mail. However, the majority of our reports are in PDF and are either available for immediate download or they are sent by email within hours of purchase.
£840.00	Disk License Disk License As described. The CD-Rom (where available) is dispatched in the post/mail. However, the majority of our reports are in PDF and are either available for immediate download or they are sent by email within hours of purchase.

£720.00	Add to Wishlist
Change Currency	GBP EURO USD

Market	Healthcare and Medical
Report Type	Market Research
Country	Asia
Published	1 November 2009
Number of Pages	100
Report Delivery	Email
Delivery Lead Time	-
Publisher	RNCOS

The world continues to witness significant shift in the global pharmaceutical market landscape, with Asia-Pacific emerging as the fastest growing pharmaceutical market over the recent past. With low costs and favorable regulatory environment, the region has seen significant developments in the field of contract manufacturing, particularly in generics and APIs. Several technological advancements have also boosted the R&D activities in the region, helping the market to grow at double digit growth rate in recent years. The size of the Asia-Pacific pharma market is estimated at around US$ 187 Billion for 2009.

According to this latest research report "Asia Pacific Pharma Sector Analysis", the future of pharma industry in the Asia-Pacific region remains bright, and the industry is projected to grow at a CAGR of around 12.6% during 2010-2012. The growth will mainly be driven by low cost factors, changing regulatory environment and increased private sector investments in the industry. Currently, the market is characterized by high growth of generics, and the same trend will continue in near future also.

We have found that the region will become the global API production hub in next few years, backed by low cost manufacturing, favorable regulatory environment and current advancements in the production technology. Also, the market will show significant changes in terms of sales and marketing model, which will be changed into tender-based model, favoring the sales of low cost drugs, and thus resulting in intense competition among key players.

Our research reveals that the pharma sales are growing rapidly in countries like India, China, Malaysia, South Korea and Indonesia. This growth is mainly attributed to the increase in disposable income along with the emergence of several health insurance schemes, which are giving a boost to the sales of branded drugs. Besides this, the intense competition among key players in the region has been easing the availability of low cost drugs, thus providing a further boost to the market growth.

Our report provides an extensive and objective analysis on the Asia-Pacific pharma market. It provides analytical and statistical information on regional level markets, including their market size and segmentation. It also features an analysis on the future directions, supplemented with various facts and figures. Thus, the report serves as a useful guide for pharmaceutical companies, government officials, consultants and investors who are planning to enter the Asia-Pacific pharma market.

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

£720.00	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£1,200.00	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.
£840.00	Hard Copy License Hard Copy License As described. Hard copy reports are dispatched in the post/mail. However, the majority of our reports are in PDF and are either available for immediate download or they are sent by email within hours of purchase.
£840.00	Disk License Disk License As described. The CD-Rom (where available) is dispatched in the post/mail. However, the majority of our reports are in PDF and are either available for immediate download or they are sent by email within hours of purchase.

£720.00	Add to Wishlist
Change Currency	GBP EURO USD

1. Analyst View
2. Global Pharmaceutical Market Overview
2.1 Market Size and Growth
2.2 Leading Drugs
3. Asia-Pacific Pharmaceutical Market Overview
4. Pharmaceutical Market By Country
4.1 China
4.1.1 Market Overview
4.1.2 Future Outlook
4.1.3 Regulatory Environment
4.2 India
4.2.1 Market Overview
4.2.2 Future Outlook
4.2.3 Regulatory Environment
4.3 Japan
4.3.1 Market Overview
4.3.2 Future Outlook
4.3.3 Regulatory Environment
4.4 South Korea
4.4.1 Market Overview
4.4.2 Future Outlook
4.4.3 Regulatory Environment
4.5 Indonesia
4.5.1 Market Overview
4.5.2 Future Outlook
4.5.3 Regulatory Environment
4.6 Vietnam
4.6.1 Market Overview
4.6.2 Future Outlook
4.6.3 Regulatory Environment
4.7 Thailand
4.7.1 Market Overview
4.7.2 Future Outlook
4.7.3 Regulatory Environment
4.8 Philippines
4.8.1 Market Overview
4.8.2 Future Outlook
4.8.3 Regulatory Environment
4.9 Malaysia
4.9.1 Market Overview
4.9.2 Future Outlook
4.9.3 Regulatory Environment
4.10 Australia
4.10.1 Market Overview
4.10.2 Future Outlook
4.10.3 Regulatory Environment
4.11 New Zealand
4.11.1 Market Overview
4.11.2 Future Outlook
4.11.3 Regulatory Environment
5. Emerging Market Trends
5.1 Contract Manufacturing
5.2 Vaccine Market
5.3 Generics
5.4 Medical Tourism Market
6. Industry Restraints and Recommendation
6.1 IPR Protection
6.2 Regulatory Issues
6.3 Reimbursement Issues
6.4 Low Investments in R&D
7. Competitive Landscape
7.1 GlaxoSmithKline plc
7.2 Pfizer Inc
7.3 Sanofi-Aventis
7.4 Ranbaxy Laboratories Limited
7.5 Takeda Pharmaceutical Company Limited

List of Figures:

Figure 2-1: Global - Pharmaceutical Market (Billion US$), 2004-2009
Figure 2-2: Global - Growth in Pharmaceutical Market (%), 2004-2008
Figure 2-3: Global - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-1: Asia-Pacific - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-2: Asia-Pacific - Pharmaceutical Market by Country (%), 2008
Figure 3-3: Asia-Pacific - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-4: Asia-Pacific - Forecast for Pharmaceutical Market by Country (%), 2012
Figure 4-1: China - Pharmaceutical Market (Billion US$), 2007-2009
Figure 4-2: China - Share of Imported and Domestically Manufactured Drugs in Pharma Market (2008)
Figure 4-3: China - Share of Generic Drugs in Pharma Market (2008)
Figure 4-4: China - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 4-5: India - Pharmaceutical Market (Billion US$), 2007-2009
Figure 4-6: India - Pharmaceutical Exports (Billion INR), 2007-08 & 2008-09
Figure 4-7: India - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 4-8: Japan - Pharmaceutical Market (Billion US$), 2007-2009
Figure 4-9: Japan - Share of Imported and Domestically Manufactured Drugs in Pharma Market (2008)
Figure 4-10: Japan - Share of Generics and Branded Drugs in Pharma Market (2008)
Figure 4-11: Japan - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 4-12: South Korea - Pharmaceutical Market (Billion US$), 2007-2009
Figure 4-13: South Korea - Share of OTC and Prescription Drugs in Pharma Market (2008)
Figure 4-14: South Korea - Share of Generics and Branded Drugs in Pharma Market (2008)
Figure 4-15: South Korea - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 4-16: Indonesia - Pharmaceutical Market (Trillion Rp), 2007-2009
Figure 4-17: Indonesia - Share of OTC and Prescription Drugs in Pharma Market (2008)
Figure 4-18: Indonesia - Share of Generics and Branded Drugs in Pharma Market (2008)
Figure 4-19: Indonesia - Forecast for Pharmaceutical Market (Trillion Rp), 2010-2012
Figure 4-20: Vietnam - Pharmaceutical Market (Billion US$), 2007-2009
Figure 4-21: Vietnam - Share of Imported and Domestically Manufactured Drugs in Pharma Market (2008)
Figure 4-22: Vietnam - Share of Generics and Branded Drugs in Pharma Market (2008)
Figure 4-23: Vietnam - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 4-24: Thailand - Pharmaceutical Market (Billion THB), 2007-2009
Figure 4-25: Thailand - Share of Imported and Domestically Manufactured Drugs in Pharma Market (2008)
Figure 4-26: Thailand - Share of Branded and Generics Drugs in Pharma Market (2008)
Figure 4-27: Thailand - Forecast for Pharmaceutical Market (Billion THB), 2010-2012
Figure 4-28: Philippines - Pharmaceutical Market (Billion PHP), 2007-2009
Figure 4-29: Philippines - Share of OTC, Prescription & Nutritional Drugs in Pharma Market (2008)
Figure 4-30: Philippines - Market Structure of the Pharmaceutical Industry
Figure 4-31: Philippines - Share of Foreign and Domestic Firms in Pharma Market (2008)
Figure 4-32: Philippines - Forecast for Pharmaceutical Market (Billion PHP), 2010-2012
Figure 4-33: Malaysia - Pharmaceutical Market (Million US$), 2007-2009
Figure 4-34: Malaysia - Share of Generics and Branded Drugs in Pharma Market (2008)
Figure 4-35: Malaysia - Share of Imported and Domestically Manufactured Drugs in Pharma Market (2008)
Figure 4-36: Malaysia - Forecast for Pharmaceutical Market (Million US$), 2010-2012
Figure 4-37: Australia - Pharmaceutical Market (Billion US$), 2007-2009
Figure 4-38: Australia - Share of Generics and Branded Drugs in Pharma Market (2008)
Figure 4-39: Australia - Pharmaceutical Export by Destination (%), 2006
Figure 4-40: Australia - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 4-41: New Zealand - Pharmaceutical Market (Billion US$), 2007-2009
Figure 4-42: New Zealand - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 5-1: Global - Pharmaceutical Contract Manufacturing Market (Billion US$), 2008-2012
Figure 5-2: Asia-Pacific - Generics Market (Billion US$), 2007-2009
Figure 5-3: Asia - Medical Tourism Market (Billion US$), 2007-2009

Lists of Tables:

Table 2-1: Global - Leading Drugs by Sales (Billion US$), 2008
Table 4-1: China - Healthcare Statistics (2007-2009)
Table 4-2: China - Timeframe for New Drug Review
Table 4-3: India - Healthcare Statistics (2007-2009)
Table 4-4: Japan - Healthcare Statistics (2007-2009)
Table 4-5: South Korea - Healthcare Statistics (2007-2009)
Table 4-6: Indonesia - Healthcare Statistics (2007-2009)
Table 4-7: Vietnam - Healthcare Statistics (2007-2009)
Table 4-8: Thailand - Healthcare Statistics (2007-2009)
Table 4-9: Philippines - Healthcare Statistics (2007-2009)
Table 4-10: Malaysia - Healthcare Statistics (2007-2009)
Table 4-11: Australia - Healthcare Statistics (2007-2009)
Table 4-12: New Zealand - Healthcare Statistics (2007-2009)
Table 7-1: GlaxoSmithKline plc - Strengths & Weaknesses
Table 7-2: Pfizer Inc - Strengths & Weaknesses
Table 7-3: Sanofi-Aventis - Strengths & Weaknesses
Table 7-4: Ranbaxy Laboratories Limited - Strengths & Weaknesses
Table 7-5: Takeda Pharmaceutical - Strengths & Weaknesses

Change Currency

GBP

EURO

USD

Last Viewed

Asia Pacific Pharmaceutical Sector Analysis

Marinas - A Global Strategic Business Report

Capcom Co. Ltd. - Financial Analysis Review

MKT Print d.d. (Slovenia) - Company Profile

Surface Active Agents - Global Market Trends

Healthcare and Medical Company Profiles

Healthcare and Medical Company Profiles contain up to date financial, strategic, operational, SWOT analysis and product information on the activities of thousands of healthcare and medical companies.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website. If a sale is made from your visitor, you earn commission (a fixed percentage of the price of a product).

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

Healthcare and Medical	Type	Keywords Phrase All Words Any Word
Microsoft Windows users can hold the CTRL Key to select more than one sector or country at a time. Apple users can hold the CMD Key to do the same.	Country	Industry Sector
Publisher	Order By Relevance Date	Published In

Asia Pacific Pharmaceutical Sector Analysis

Select License Type

Speak to an Advisor

Select License Type

Table of Contents

Change Currency

Last Viewed

Healthcare and Medical Company Profiles

Become an Affiliate

Custom Research

News

Market Insights

Companies And Markets

Customer Support

Corporate Accounts

Contact Details

Contrast settings

Text size settings

All
Afghanistan
Africa
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Asia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia-Herzegovina
Botswana
Bouvet Island
Brazil
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Caribbean
Cayman Islands
Central African Republic
Central America
Central Europe
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Conch Republic
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Democratic Republic of Congo
Denmark
Djibouti
Dominica
Dominican Republic
Eastern Europe
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Europe
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Global
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guernsey
Guinea
Guinea Bissau
Guyana
Haiti
Heard Island and McDonald Islans
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Ivory Coast (Cote D`Ivoire)
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kurdistan
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Middle East
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North America
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Saint Barthelemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Scandinavia
Schengen countries
Senegal
Serbia and Montenegro
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South America
South Georgia and the South Sandwich Islands
South Korea
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste (East Timor)
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands
Wallis and Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe

All
Aerospace
Agriculture, Farming & Raw Materials
Automotive and Parts
Business Services
Chemicals
Construction
Consumer Goods
Defence
Energy and Utilities
Environmental
Finance and Banking
Food and Drink
Healthcare and Medical
Industrial
Information Technology
Leisure
Logistics
Media
Paper and Packaging
Publishing and Printing
Real Estate
Retail
Security
Telecommunications
Textiles and Clothing
Transportation
Travel